Orelabrutinib Combined With Pola-R-CHP Regimen for the Treatment of Untreated Non-GCB Diffuse Large B-Cell Lymphoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Orelabrutinib Combined With Pola-R-CHP Regimen for the Treatment of Untreated Non-GCB Diffuse Large B-Cell Lymphoma	B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm	Recruiting	Phase 2	2025-08-19		NCT07078500

17 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Jiaxing University	36
Dongyang People's Hospital	16
First People's Hospital of Hangzhou	58
Huzhou Central Hospital	31
Ningbo People's Hospital	2
Second Affiliated Hospital of Wenzhou Medical University	81
Second Affiliated Hospital, Zhejiang University, School of Medicine	561
Shaoxing Central Hospital	8
Shaoxing People's Hospital	24
Taizhou First People's Hospital	10
Taizhou Hospital	28
The Central Hospital of Lishui City	21
The People's Hospital of Quzhou	6
The Second Affiliated Hospital of Jiaxing University	22
Yuyao People's Hospital	5
Zhejiang Cancer Hospital	142
Zhuji People's Hospital of Zhejiang Province	4

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Second Affiliated Hospital, School of Medicine, Zhejiang University	Hangzhou	China	17